LOXO-783

· Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for LOXO-783, covering 2024-07-22 to 2026-04-20. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors [Phase 1]